128 related articles for article (PubMed ID: 2499202)
1. Physiological activation of the mitochondrion and the transformation capacity of DFMO induced intermediate and short stumpy bloodstream form trypanosomes.
Giffin BF; McCann PP
Am J Trop Med Hyg; 1989 May; 40(5):487-93. PubMed ID: 2499202
[TBL] [Abstract][Full Text] [Related]
2. Polyamine depletion following exposure to DL-alpha-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei.
Giffin BF; McCann PP; Bitonti AJ; Bacchi CJ
J Protozool; 1986 May; 33(2):238-43. PubMed ID: 3090240
[TBL] [Abstract][Full Text] [Related]
3. Altered intracellular polyamines in bloodstream form Trypanosoma brucei brucei: transformation to procyclic trypomastigotes.
Giffin BF; McCann PP
Acta Trop; 1993 Nov; 55(3):181-90. PubMed ID: 7903840
[TBL] [Abstract][Full Text] [Related]
4. Effect of putrescine on the respiration of Trypanosoma brucei brucei.
Giffin BF; McCann PP; Bacchi CJ
Mol Biochem Parasitol; 1986 Aug; 20(2):165-71. PubMed ID: 3092047
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei.
Bacchi CJ; Garofalo J; Mockenhaupt D; McCann PP; Diekema KA; Pegg AE; Nathan HC; Mullaney EA; Chunosoff L; Sjoerdsma A; Hutner SH
Mol Biochem Parasitol; 1983 Mar; 7(3):209-25. PubMed ID: 6193423
[TBL] [Abstract][Full Text] [Related]
6. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
Breton JC; Bouteille B; Sonan T
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
[TBL] [Abstract][Full Text] [Related]
7. A proposed density-dependent model of long slender to short stumpy transformation in the African trypanosomes.
Seed JR; Black SJ
J Parasitol; 1997 Aug; 83(4):656-62. PubMed ID: 9267408
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma brucei brucei and T. b. gambiense: stumpy bloodstream forms express more CB1 epitope in endosomes and lysosomes than slender forms.
Brickman MJ; Balber AE
J Eukaryot Microbiol; 1994; 41(6):533-6. PubMed ID: 7532512
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma brucei: in vitro slender-to-stumpy differentiation of culture-adapted, monomorphic bloodstream forms.
Breidbach T; Ngazoa E; Steverding D
Exp Parasitol; 2002 Aug; 101(4):223-30. PubMed ID: 12594963
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei.
Fairlamb AH; Henderson GB; Bacchi CJ; Cerami A
Mol Biochem Parasitol; 1987 Jun; 24(2):185-91. PubMed ID: 3114634
[TBL] [Abstract][Full Text] [Related]
11. Morphological changes in Trypanosoma brucei rhodesiense following inhibition of polyamine biosynthesis in vivo.
de Gee AL; Carstens PH; McCann PP; Mansfield JM
Tissue Cell; 1984; 16(5):731-8. PubMed ID: 6440309
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the oligomycin-sensitive ATPase in bloodstream forms of Trypanosoma brucei brucei.
Bienen EJ; Shaw MK
Mol Biochem Parasitol; 1991 Sep; 48(1):59-66. PubMed ID: 1838138
[TBL] [Abstract][Full Text] [Related]
13. Validation of spermidine synthase as a drug target in African trypanosomes.
Taylor MC; Kaur H; Blessington B; Kelly JM; Wilkinson SR
Biochem J; 2008 Jan; 409(2):563-9. PubMed ID: 17916066
[TBL] [Abstract][Full Text] [Related]
14. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture.
Nishimura K; Yanase T; Araki N; Ohnishi Y; Kozaki S; Shima K; Asakura M; Samosomsuk W; Yamasaki S
J Parasitol; 2006 Apr; 92(2):211-7. PubMed ID: 16729674
[TBL] [Abstract][Full Text] [Related]
15. Cell density triggers slender to stumpy differentiation of Trypanosoma brucei bloodstream forms in culture.
Reuner B; Vassella E; Yutzy B; Boshart M
Mol Biochem Parasitol; 1997 Dec; 90(1):269-80. PubMed ID: 9497048
[TBL] [Abstract][Full Text] [Related]
16. Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine.
Bitonti AJ; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1986 Jan; 35(2):331-4. PubMed ID: 3080008
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation differences among proteins of bloodstream developmental stages of Trypanosoma brucei brucei.
Aboagye-Kwarteng T; ole-MoiYoi OK; Lonsdale-Eccles JD
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):7-14. PubMed ID: 2018486
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
Li F; Hua SB; Wang CC; Gottesdiener KM
Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
[TBL] [Abstract][Full Text] [Related]
19. The effects of the methylating agent 1,2-bis(methylsulfonyl)-1-methylhydrazine on morphology, DNA content and mitochondrial function of Trypanosoma brucei subspecies.
Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
J Protozool; 1991; 38(3):172-7. PubMed ID: 1880758
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
Onyeyili PA; Onwualu JE
Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
